Last reviewed · How we verify
Local Anesthesia for Urethral Pain
Approved treatments
- Lignocaine · University of Malaya
- Lignospan Forte · Fresenius Kabi
Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction. - Lidocain · Bayer
- xylocain · Saint-Joseph University
Clinical guidelines
- FDA label — 1L
Lidocaine is indicated for local anesthesia for urethral pain. - FDA label — 1L
Lidocaine is indicated for local anesthesia for urethral pain.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Local Anesthesia for Urethral Pain patent landscape — cliff calendar, originator estates, attackable patents
- Local Anesthesia for Urethral Pain treatment landscape brief
- Local Anesthesia for Urethral Pain treatment updates RSS
Frequently asked questions about Local Anesthesia for Urethral Pain
What drugs treat Local Anesthesia for Urethral Pain?
Tracked treatments include Lignocaine, Lignospan Forte, Lidocain, xylocain.
What is the treatment for Local Anesthesia for Urethral Pain?
Standard treatment for Local Anesthesia for Urethral Pain includes Lignocaine, Lignospan Forte, Lidocain, xylocain. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Local Anesthesia for Urethral Pain?
FDA label publishes guidelines for Local Anesthesia for Urethral Pain. 2 guideline references tracked.
Related
- Treatment landscape: Local Anesthesia for Urethral Pain patent cliff · Local Anesthesia for Urethral Pain CI report
- Treatment: Lignocaine · University of Malaya
- Treatment: Lignospan Forte · Fresenius Kabi
- Treatment: Lidocain · Bayer
- Treatment: xylocain · Saint-Joseph University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing